Latest News

Welcome to the Alfred Research Alliance news hub. To catch up on the news from our Alliance members, please click on the links below:

Monash epilepsy CBD trial

Around the Precinct – 14 July 2022

A world-first trial into the benefits of transdermal CBD gel for adults with epilepsy, a rethink on the use of painkillers for heart attacks, and the impact of COVID-19 lockdowns on diabetes management – this week at the Alfred Research Alliance. Monash University – Central Clinical School World first Australian and New Zealand trial of… Read More

NAIDOC Week

Around the Precinct – 7 July 2022

This week (3-10 July) is NAIDOC Week, which celebrates and recognises the history, culture and achievements of Aboriginal and Torres Strait Islander peoples. To mark this important week, our partners have taken the opportunity to explore how health services can better meet the needs of First Nations people, as well as investigate some of the specific… Read More

Baker Heart and Diabetes Institute

Around the Precinct – 30 June 2022

As the first half of 2022 draws to a close, our researchers continue to investigate various aspects of the COVID-19 pandemic, including an examination of the mortality rates during the third wave in 2021 and the need for a vaccines-plus strategy to reduce current transmission and defend against future variants. Meanwhile, other Alliance scientists are… Read More

Paula Fox Melanoma and Cancer Centre

Around the Precinct – 23 June 2022

The precinct celebrated an important milestone this week as building commenced on the Paula Fox Melanoma and Cancer Centre at The Alfred. The state-of-the-art facility is due to be completed in early 2024 and will offer advanced cancer care for patients as well as extending the reach of the precinct’s world-leading clinical trials. This week… Read More